32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Homologous desensitization of signalling by the alpha (α) isoform of the human thromboxane A 2 receptor: A specific role for nitric oxide signalling

      research-article
      , , , *
      Biochimica et Biophysica Acta
      Elsevier Pub. Co
      C-tail, carboxyl-terminal tail, [Ca2+]i, intracellular calcium, COX, cyclooxygenase, FBS, foetal bovine serum, GPCR, G protein-coupled receptor, GRK, G protein-coupled receptor kinase, HA, hemagglutinin, HEK, human embryonic kidney, IP, prostacyclin receptor, IP3, inositol 1, 4, 5-trisphosphate, NO, nitric oxide, NOS, nitric oxide synthase, PAGE, polyacrylamide gel electrophoresis, PG, prostaglandin, PK, protein kinase, PL, phospholipase, sGC, soluble guanylyl cyclase, TP, TXA2 receptor, TX, thromboxane, Thromboxane receptor, Alpha, Desensitization, Phosphorylation, Nitric oxide, G protein coupled receptor

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Thromboxane (TX) A 2 plays a central role in hemostasis, regulating platelet activation status and vascular tone. We have recently established that the TPβ isoform of the human TXA 2 receptor (TP) undergoes rapid, agonist-induced homologous desensitization of signalling largely through a G protein-coupled receptor kinase (GRK) 2/3-dependent mechanism with a lesser role for protein kinase (PK) C. Herein, we investigated the mechanism of desensitization of signalling by the TPα isoform. TPα undergoes profound agonist-induced desensitization of signalling (intracellular calcium mobilization and inositol 1,4,5 trisphosphate generation) in response to the TXA 2 mimetic U46619 but, unlike that of TPβ, this is independent of GRKs. Similar to TPβ, TPα undergoes partial agonist-induced desensitization that occurs through a GF 109203X-sensitive, PKC mechanism where Ser 145 within intracellular domain (IC) 2 represents the key phospho-target. TPα also undergoes more profound sustained PKC- and PKG-dependent desensitization where Thr 337 and Ser 331, respectively, within its unique C-tail domain were identified as the phospho-targets. Desensitization was impaired by the nitric oxide synthase (NOS), soluble guanylyl cyclase (sGC) and PKG inhibitors l-NAME, LY 83583 and KT5823, respectively, indicating that homologous desensitization of TPα involves nitric oxide generation and signalling. Consistent with this, U46619 led to rapid phosphorylation/activation of endogenous eNOS. Collectively, data herein suggest a mechanism whereby agonist-induced PKC phosphorylation of Ser 145 partially and transiently impairs TPα signalling while PKG- and PKC-phosphorylation at both Ser 331 and Thr 337, respectively, within its C-tail domain profoundly desensitizes TPα, effectively terminating its signalling. Hence, in addition to the agonist-mediated PKC feedback mechanism, U46619-activation of the NOS/sGC/PKG pathway plays a significant role in inducing homologous desensitization of TPα.

          Related collections

          Most cited references79

          • Record: found
          • Abstract: found
          • Article: not found

          Transduction of receptor signals by beta-arrestins.

          The transmission of extracellular signals to the interior of the cell is a function of plasma membrane receptors, of which the seven transmembrane receptor family is by far the largest and most versatile. Classically, these receptors stimulate heterotrimeric G proteins, which control rates of generation of diffusible second messengers and entry of ions at the plasma membrane. Recent evidence, however, indicates another previously unappreciated strategy used by the receptors to regulate intracellular signaling pathways. They direct the recruitment, activation, and scaffolding of cytoplasmic signaling complexes via two multifunctional adaptor and transducer molecules, beta-arrestins 1 and 2. This mechanism regulates aspects of cell motility, chemotaxis, apoptosis, and likely other cellular functions through a rapidly expanding list of signaling pathways.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prostanoid receptors: structures, properties, and functions.

            Prostanoids are the cyclooxygenase metabolites of arachidonic acid and include prostaglandin (PG) D(2), PGE(2), PGF(2alpha), PGI(2), and thromboxne A(2). They are synthesized and released upon cell stimulation and act on cells in the vicinity of their synthesis to exert their actions. Receptors mediating the actions of prostanoids were recently identified and cloned. They are G protein-coupled receptors with seven transmembrane domains. There are eight types and subtypes of prostanoid receptors that are encoded by different genes but as a whole constitute a subfamily in the superfamily of the rhodopsin-type receptors. Each of the receptors was expressed in cultured cells, and its ligand-binding properties and signal transduction pathways were characterized. Moreover, domains and amino acid residues conferring the specificities of ligand binding and signal transduction are being clarified. Information also is accumulating as to the distribution of these receptors in the body. It is also becoming clear for some types of receptors how expression of their genes is regulated. Furthermore, the gene for each of the eight types of prostanoid receptor has been disrupted, and mice deficient in each type of receptor are being examined to identify and assess the roles played by each receptor under various physiological and pathophysiological conditions. In this article, we summarize these findings and attempt to give an overview of the current status of research on the prostanoid receptors.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

              Nitric oxide (NO), a potent vasodilator produced by endothelial cells, is thought to be the endothelium-dependent relaxing factor (EDRF) which mediates vascular relaxation in response to acetylcholine, bradykinin and substance P in many vascular beds. NO has been implicated in the regulation of blood pressure and regional blood flow, and also affects vascular smooth-muscle proliferation and inhibits platelet aggregation and leukocyte adhesion. Abnormalities in endothelial production of NO occur in atherosclerosis, diabetes and hypertension. Pharmacological blockade of NO production with arginine analogues such as L-nitroarginine (L-NA) or L-N-arginine methyl ester affects multiple isoforms of nitric oxide synthase (NOS), and so cannot distinguish their physiological roles. To study the role of endothelial NOS (eNOS) in vascular function, we disrupted the gene encoding eNOS in mice. Endothelium-derived relaxing factor activity, as assayed by acetylcholine-induced relaxation, is absent, and the eNOS mutant mice are hypertensive. Thus eNOS mediates basal vasodilation. Responses to NOS blockade in the mutant mice suggest that non-endothelial isoforms of NOS may be involved in maintaining blood pressure.
                Bookmark

                Author and article information

                Journal
                Biochim Biophys Acta
                Biochimica et Biophysica Acta
                Elsevier Pub. Co
                0006-3002
                June 2007
                June 2007
                : 1773
                : 6
                : 970-989
                Affiliations
                School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
                Author notes
                [* ]Corresponding author. Tel.: +353 1 7166727; fax: +353 1 2837211. Therese.Kinsella@ 123456ucd.ie
                Article
                BBAMCR15611
                10.1016/j.bbamcr.2007.03.012
                2680961
                17466390
                cd39fa76-897c-4243-abc6-db890d65d0c4
                © 2007 Elsevier B.V.

                This document may be redistributed and reused, subject to certain conditions.

                History
                : 23 January 2007
                : 14 March 2007
                : 15 March 2007
                Categories
                Article

                Biochemistry
                nos, nitric oxide synthase,desensitization,no, nitric oxide,[ca2+]i, intracellular calcium,pk, protein kinase,g protein coupled receptor,thromboxane receptor,ha, hemagglutinin,nitric oxide,fbs, foetal bovine serum,alpha,hek, human embryonic kidney,phosphorylation,ip3, inositol 1, 4, 5-trisphosphate,ip, prostacyclin receptor,grk, g protein-coupled receptor kinase,pg, prostaglandin,page, polyacrylamide gel electrophoresis,gpcr, g protein-coupled receptor,sgc, soluble guanylyl cyclase,c-tail, carboxyl-terminal tail,pl, phospholipase,tp, txa2 receptor,tx, thromboxane,cox, cyclooxygenase

                Comments

                Comment on this article